Cover Image
市場調查報告書

抗菌藥敏銳度檢驗 (AST)的全球市場 - 至2022年的預測:自動系統,光碟,MIC帶,培養基

Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 602136
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
抗菌藥敏銳度檢驗 (AST)的全球市場 - 至2022年的預測:自動系統,光碟,MIC帶,培養基 Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User - Global Forecast to 2022
出版日期: 2018年01月26日 內容資訊: 英文 167 Pages
簡介

全球抗菌藥敏銳度檢驗 (AST) 市場,預計從2017年的27億1000萬美元,到2022年擴大到34億7000萬美元。預計市場2017年∼2022年以5.1%的年複合成長率成長。

本報告提供全球抗菌藥敏銳度檢驗 (AST) 市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 抗菌藥敏銳度檢驗 (AST) 市場的富有魅力的機會
  • 抗菌藥敏銳度檢驗 (AST) 市場:各方法
  • 各地區分析 - 抗菌藥敏銳度檢驗 (AST) 市場:各地區、產品
  • 抗菌藥敏銳度檢驗 (AST) 市場:各類型
  • 抗菌藥敏銳度檢驗 (AST) 市場:各應用
  • 抗菌藥敏銳度檢驗 (AST) 市場:各終端用戶
  • 抗菌藥敏銳度檢驗 (AST) 市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 市場趨勢

第6章 抗菌藥敏銳度檢驗 (AST)的全球市場:各方法

  • 簡介
  • 光碟擴散
  • 自動AST
  • 稀釋
  • Etest
  • 遺傳基因型

第7章 抗菌藥敏銳度檢驗 (AST)的全球市場:各產品

  • 簡介
  • 手動AST產品
  • 自動儀器
  • 培養基,增生培養基
  • 消耗品

第8章 抗菌藥敏銳度檢驗 (AST)的全球市場:各類型

  • 簡介
  • 抗菌性
  • 抗真菌性
  • 抗寄生蟲性
  • 其他

第9章 抗菌藥敏銳度檢驗 (AST)的全球市場:各應用

  • 簡介
  • 臨床診斷
  • 藥物研發、開發
  • 流行病學
  • 其他

第10章 抗菌藥敏銳度檢驗 (AST)的全球市場:各終端用戶

  • 簡介
  • 臨床檢驗室、醫院
  • 製藥、生物企業
  • 研究、學術機構
  • 臨床研究委外機構 (CRO)

第11章 抗菌藥敏銳度檢驗 (AST)的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 競爭情形

  • 簡介
  • 企業的排行榜
  • 競爭模式

第13章 企業簡介

  • BIOMERIEUX
  • DANAHER
  • BD
  • THERMO FISHER
  • BIO-RAD
  • HI-MEDIA
  • MERLIN
  • LIOFILCHEM
  • ACCELERATE DIAGNOSTICS
  • ALIFAX
  • CREATIVE DIAGNOSTICS
  • MERCK GROUP
  • SYNBIOSIS
  • BIOANALYSE
  • ZHUHAI DL BIOTECH

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 5931

"The antimicrobial susceptibility testing market projected to grow at a CAGR of 5.1% during the forecast period."

The global antimicrobial susceptibility testing market is projected to reach USD 3.47 billion by 2022 from USD 2.71 billion in 2017, at a CAGR of 5.1%. The major factors driving the growth of the market include the rising prevalence of infectious diseases; emergence of multidrug-resistance due to drug abuse; and increasing funds, research grants, and public-private investments. However, the high cost of automated antimicrobial susceptibility testing systems and unfavorable reimbursement scenario are restraining the growth of this market.

"The automated antimicrobial susceptibility testing segment is expected to grow at the highest rate during the forecast period."

On the basis of product, the global antimicrobial susceptibility testing market is segmented automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The automated laboratory instruments segment is estimated to witness the highest growth during the forecast period, primarily due to on-going technological advancements and increasing demand for faster susceptibility testing systems.

"The disk diffusion segment accounted for the largest share of antimicrobial susceptibility testing market by method."

On the basis of method, the antimicrobial susceptibility testing market is segmented into disk diffusion, dilution, ETEST, automated antimicrobial susceptibility testing, and genotypic methods. The disk diffusion segment is expected to have the largest share of the market in 2017. This is mainly attributed to factors such as its low cost and flexible nature.

"The APAC market is expected to grow at the highest CAGR during the forecast period."

Geographically, the antimicrobial susceptibility testing market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The APAC market is expected to register the highest growth rate during the forecast period. The fast growth of this segment is mainly due to the region's large population and its mix of growing and developed economies, such as Japan, China, and India. Moreover, as markets in developed countries are increasingly becoming saturated, manufacturers and suppliers of antimicrobial susceptibility testing products are shifting their focus towards the Asian market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 - 25%, Tier 2 - 30% and Tier 3 - 45%
  • By Designation - C-level - 26%, Director level - 30%, Others - 44%
  • By Region - North America - 34%, Europe - 26%, APAC - 23%, RoW - 17%

The major players in the market included are bioMerieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US).

Research Coverage:

This report studies the antimicrobial susceptibility testing market based on product, method, type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the antimicrobial susceptibility testing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING
  • 4.2 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD
  • 4.3 GEOGRAPHIC ANALYSIS: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION & PRODUCT
  • 4.4 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE
  • 4.5 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION
  • 4.6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER
  • 4.7 GEOGRAPHICAL SNAPSHOT OF THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS

    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of infectious diseases
      • 5.2.1.2 Increased funding, research grants, and public-private investments
      • 5.2.1.3 Technological advancements towards the development of rapid AST methods
      • 5.2.1.4 Emergence of multidrug resistance due to drug abuse
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement scenario
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets to offer lucrative opportunities
      • 5.2.3.2 Initiatives to detect and control antimicrobial-resistant species
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High cost of automated antimicrobial susceptibility testing systems
      • 5.2.4.2 Lack of coordination between regulatory bodies, clinical laboratories, and AST manufacturers
  • 5.3 MARKET TRENDS

6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD

  • 6.1 INTRODUCTION
  • 6.2 DISK DIFFUSION
  • 6.3 AUTOMATED AST
  • 6.4 DILUTION
  • 6.5 ETEST
  • 6.6 GENOTYPIC METHODS

7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
  • 7.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
    • 7.2.1 SUSCEPTIBILITY TESTING DISKS
    • 7.2.2 MIC STRIPS
    • 7.2.3 SUSCEPTIBILITY PLATES
  • 7.3 AUTOMATED LABORATORY INSTRUMENTS
  • 7.4 CULTURE AND GROWTH MEDIA
  • 7.5 CONSUMABLES

8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 ANTIBACTERIAL SUSCEPTIBILITY TESTING
  • 8.3 ANTIFUNGAL SUSCEPTIBILITY TESTING
  • 8.4 ANTIPARASITIC SUSCEPTIBILITY TESTING
  • 8.5 OTHER SUSCEPTIBILITY TESTING

9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 CLINICAL DIAGNOSTICS
  • 9.3 DRUG DISCOVERY AND DEVELOPMENT
  • 9.4 EPIDEMIOLOGY
  • 9.5 OTHER APPLICATIONS

10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 DIAGNOSTIC LABORATORIES AND HOSPITALS
  • 10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 10.4 RESEARCH AND ACADEMIC INSTITUTES
  • 10.5 CONTRACT RESEARCH ORGANIZATIONS

11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
  • 11.3 EUROPE
  • 11.4 ASIA PACIFIC
  • 11.5 REST OF THE WORLD

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 RANKING OF PLAYERS, 2016
  • 12.3 COMPETITIVE SCENARIO
    • 12.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS
    • 12.3.2 ACQUISITIONS
    • 12.3.3 AGREEMENTS AND COLLABORATIONS
    • 12.3.4 EXPANSIONS

13 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 13.1 BIOMERIEUX
  • 13.2 DANAHER
  • 13.3 BD
  • 13.4 THERMO FISHER
  • 13.5 BIO-RAD
  • 13.6 HI-MEDIA
  • 13.7 MERLIN
  • 13.8 LIOFILCHEM
  • 13.9 ACCELERATE DIAGNOSTICS
  • 13.10 ALIFAX
  • 13.11 CREATIVE DIAGNOSTICS
  • 13.12 MERCK GROUP
  • 13.13 SYNBIOSIS
  • 13.14 BIOANALYSE
  • 13.15 ZHUHAI DL BIOTECH

Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5 AVAILABLE CUSTOMIZATIONS
  • 14.6 RELATED REPORTS
  • 14.7 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 2: GLOBAL DISK DIFFUSION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL AUTOMATED AST MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: GLOBAL DILUTION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL ETEST MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: GLOBAL GENOTYPIC METHODS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 8: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: SUSCEPTIBILITY TESTING DISKS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MIC STRIPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: SUSCEPTIBILITY PLATES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: AUTOMATED LABORATORY INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: CULTURE AND GROWTH MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: ANTIBACTERIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: ANTIFUNGAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: ANTIPARASITIC SUSCEPTIBILITY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: OTHER SUSCEPTIBILITY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: GLOBAL EPIDEMIOLOGY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DIAGNOSTIC LABORATORIES AND HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CROS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 39: US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 40: US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 43: CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 59: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 60: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 62: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: DATA TRIANGULATION
  • FIGURE 5: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2017
  • FIGURE 6: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS WILL CONTINUE TO HOLD LARGEST SHARE IN 2022
  • FIGURE 7: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2017 (USD MILLION)
  • FIGURE 8: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2017 (USD MILLION)
  • FIGURE 9: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 11: RISING PREVALENCE OF INFECTIOUS DISEASES-MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 12: DISK DIFFUSION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2022
  • FIGURE 13: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017
  • FIGURE 14: ANTIBACTERIAL SUSCEPTIBILITY TESTING SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2022
  • FIGURE 15: CLINICAL DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2022
  • FIGURE 16: HOSPITALS & DIAGNOSTIC LABORATORIES TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 17: ASIA PACIFIC TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 18: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: DEATHS ATTRIBUTABLE TO ANTIMICROBIAL RESISTANCE PER YEAR BY 2050
  • FIGURE 20: DISK DIFFUSION SEGMENT TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING METHOD MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: SUSCEPTIBILITY TESTING DISKS TO DOMINATE THE MANUAL AST PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: ANTIBACTERIAL TESTING SEGMENT TO DOMINATE THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017
  • FIGURE 24: CLINICAL DIAGNOSTICS SEGMENT TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017
  • FIGURE 25: DIAGNOSTIC LABORATORIES AND HOSPITALS SEGMENT TO DOMINATE THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017
  • FIGURE 26: NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
  • FIGURE 27: EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
  • FIGURE 28: ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
  • FIGURE 29: ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
  • FIGURE 30: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2014-2017
  • FIGURE 31: BIOMERIEUX HELD THE LEADING POSITION IN THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2016
  • FIGURE 32: BIOMERIEUX: COMPANY SNAPSHOT
  • FIGURE 33: DANAHER: COMPANY SNAPSHOT
  • FIGURE 34: BD: COMPANY SNAPSHOT
  • FIGURE 35: THERMO FISHER: COMPANY SNAPSHOT
  • FIGURE 36: BIO-RAD: COMPANY SNAPSHOT
  • FIGURE 37: ACCELERATE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 38: MERCK GROUP: COMPANY SNAPSHOT
Back to Top